This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Semaglutide is the active ingredient in popular injectable weight-loss drugs.
The FDA is also investigating reported side effects of aspiration.
Some people have taken 10 times the recommended dose or even the entire month’s dose due to confusion about the directions.
The company said it conducted tests on compounded drugs that claim to contain semaglutide and found ‘concerning levels of unknown impurities.’
A new class of weight-loss drug shows it can significantly reduce heart disease-related death in people without diabetes.
The U.S. Food and Drug Administration has urged online vendors to stop selling unapproved semaglutide and tirzepatide drugs due to public health concerns.
Ozempic and Wegovy may help people lose weight but are associated with a long list of very serious side effects.
